CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF) is moving in the right direction again after several months of necessary consolidation. The stock popped to highs of $14.39 in November before the sector crashed on misguided mania that thought Trumps election would be bad for the industry; of course the opposite has been true with the markets skyrocketing in recent months.
TWMJF operates in the red hot Marijuana industry that has quickly turned into a multi-billion dollar massive growth market that is sweeping across the US and Canada with many new states legalizing the drug including California, Nevada, Maine, and Massachusetts on November 8.. Medical marijuana products in the U.S. alone are projected to generate an estimated $30-35 Billion in revenue by 2020.
CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF) is Canada’s first publicly traded medical marijuana company and the first geographically diversified producer with multiple licenses under the Marihuana for Medical Purposes Regulations. Through its wholly owned subsidiaries, Tweed, Tweed Farms, and Bedrocan, it operates three state-of-the-art production facilities in Ontario and distributes marijuana across the country to Canadian patients managing a host of medical conditions. Canopy Growth is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, conducting robust clinical research, and furthering the public’s understanding of how marijuana is used for medical purposes.
TWMJF core brands include Tweed, the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.
TWMJF other core brand is Bedrocan, the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.
To Find out the inside Scoop on TWMJF Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
In October TWMJF announced a consulting agreement with Nutritional High International Inc with a focus on developing TWMJF cannabis extracts product offerings in Canada. Nutritional High will be involved in various capacities including identifying equipment and developing manufacturing processes related to cannabis extracts. The partnership demonstrates the recognition of the Company’s expertise in the industry and Nutritional High looks forward to working with the Canopy team to share its findings in the field.
On February 2 TWMJF announced its share ticker will change to TSX:WEED upon the commencement of trading on the Toronto Stock Exchange (“TSX”) on February 1, 2017.
“Patients, investors and Canadians as a whole are more accepting of the cannabis sector today than ever before,” said Bruce Linton, Chairman and CEO of Canopy Growth. “This is owed to a lot of factors, but we are proud to have played our part in introducing a once-stigmatized topic into Main Street and Bay Street conversations. From our beginnings in an abandoned chocolate factory, to our funding of research to our countless doctor interactions, we have always taken pride in putting people at ease to open the door to a more meaningful conversation. Now, over three years later, we’re thrilled to be marketing WEED on Bay Street.”
The ticker symbol change comes at a transformative time for Canopy Growth. On January 27th, 2017, shareholders voted overwhelmingly in favour of a previously announced acquisition of Mettrum Health Corp. All conditions of an arrangement agreement dated November 30, 2016, as amended, and previously announced by the Companies on December 1, 2016 have been met and the transaction is now officially closed.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $995 million market valuation and running up the charts TWMJF has $14.7 million in the treasury as well as $23 million in total assets. TWMJF is an exciting story developing in the Canadian legal Marijuana industry; the Company is the largest Marijuana producer in Canada and with global ambitions and the recent partnership with Snoop Dogg gives them substantially more visibility. TWMJF is a must own stock for Investors in pot stocks. We will be updating on TWMJF when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with TWMJF.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in TWMJF either long or short and we have not been compensated for this article.